Pathological Gambling Clinical Trial
Official title:
The Role of Neuromodulation for Cognitive Processing and Behavioural Inhibition in Gambling Disorder
Verified date | April 2019 |
Source | University of East London |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Gambling disorder is associated to high impulsivity and excessive risk-taking behaviour.
These behavioural characteristics related to addiction are linked to cognitive processes in
specific brain areas located in the prefrontal cortex (PFC).
With the aim of studying the role of PFC in gambling disorder, the investigators employ
transcranial current direct stimulation (tDCS), a noninvasive brain stimulation technique
that applies a very weak electrical current to the superficial areas of the brain.
The clinical phase of the research consists on studying the effects of tDCS in combination
with cognitive behavioural therapy (CBT) in patients that attend the United Kingdom (UK)
National Problem Gambling Clinic. The main objective of the project is to investigate whether
the combination of tDCS and CBT can help to decrease impulsivity and risk-taking behaviour
and therefore improve the treatment for gambling disorder.
Status | Enrolling by invitation |
Enrollment | 32 |
Est. completion date | September 1, 2020 |
Est. primary completion date | April 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Male or females between 18-65 years old diagnosed with disordered gambling based on the Problem Gambling Severity Index (PGSI) who can speak and read English and don't have any of the exclusion criteria. Exclusion Criteria: 1. History or evidence of chronic or residual neurological disease. 2. A pacemaker or deep brain stimulation. 3. Metal implants in head or neck area (e.g. postoperative clips after intracerebral aneurysm; arterial aneurysm in the vascular system, implantation of an artificial hearing aid). 4. Intracerebral ischemia/history of bleeding. 5. Prior evidence of epileptic seizures, history of epilepsy. 6. History of head injury with loss of consciousness. 7. Any serious medical conditions (disease of the internal organs). 8. Pregnancy or breast-feeding. 9. Negative prescreening from the clinic psychiatrist. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University of East London | London |
Lead Sponsor | Collaborator |
---|---|
University of East London | GambleAware, National Problem Gambling Clinic |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in scores on the Yale-Brown Obsessive Compulsive Scale adapted for Pathological Gambling (PG-YBOCS) | It is a 10-item questionnaire that measures the gambling severity. The scores range from 0 to 4 in each question and the total score ranges from 0 to 40. The questions 1 to 5 assess urges and thoughts associated with gambling disorder, and the rest assess the behavioral component of the disorder. The total score will be calculated as well as the separate scores. Gambling severity will be higher with higher PG-YBOCS scores. | Change from baseline PG-YBOCS scores at week 2, 3, 4, 5, 6, 7 and 8 | |
Primary | Change in scores on the Visual Analogue Scale (VAS) | It is a horizontal line which length is 100 mm where the left side corresponds to the lower scores and the right side to the highest scores (it ranges from 0 to 10). The participant will draw a line where the level best represents their gambling cravings at the current time. The score will be calculated by measuring this line (in millimetres). The gambling cravings will be higher with higher VAS scores. | Change from baseline VAS scores at week 2, 3, 4, 5, 6, 7 and 8 | |
Primary | Change in scores on the Gambling Symptom Assessment Scale (G-SAS) | It is a 12-item scale to measure gambling symptoms. Each of the 12 questions has a score ranging from 0 to 4 based on the last week. It is useful to measure changes during treatment. The total score ranges from 0 to 48. The symptoms severity will be higher with higher G-SAS scores. | Change from baseline G-SAS scores at week 8 | |
Primary | Change in scores on the Cambridge Gambling Task (CGT) | Measures of gambling behaviour. | Change from baseline CGT scores at week 8 | |
Secondary | Change in scores on the Information Sampling Task (IST) | Measures of impulsivity | Change from baseline IST scores at week 2, 3, 4, 5, 6, 7 and 8 | |
Secondary | Change in scores on the Stop Signal Task (SST) | Measures of control inhibition | Change from baseline IST scores at week 2, 3, 4, 5, 6, 7 and 8 | |
Secondary | Change in encephalography (EEG) activity | Measures of endogenous oscillatory neural activity | Change from baseline EEG activity in weeks 1, 2, 3, 4, 5, 6, 7 and 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02590211 -
Poker, Skills and Associated Problems
|
N/A | |
Completed |
NCT02203786 -
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
|
Phase 2 | |
Completed |
NCT05051085 -
Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling
|
N/A | |
Completed |
NCT01215357 -
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
|
Phase 2 | |
Terminated |
NCT00245583 -
Topiramate in the Treatment of Pathological Gambling
|
Phase 3 | |
Completed |
NCT04842461 -
Mental Health, Addictions and Biomarkers in High Athletes Performance
|
||
Not yet recruiting |
NCT03280966 -
Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder
|
Phase 2 | |
Active, not recruiting |
NCT01743092 -
Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment
|
N/A | |
Active, not recruiting |
NCT01528982 -
Susceptibility to Pathological Gambling
|
N/A | |
Terminated |
NCT00211822 -
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
|
N/A | |
Completed |
NCT01381250 -
Effects of Internet-based Treatment of Pathological Gambling
|
N/A | |
Completed |
NCT05506384 -
Treatment Study for Problematic Gaming and Gambling
|
N/A | |
Terminated |
NCT01560351 -
Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study
|
N/A | |
Completed |
NCT00580567 -
Impulsivity in Pathological Gambling
|
N/A | |
Completed |
NCT02240485 -
Integrative Couple Treatment for Pathological Gambling
|
N/A | |
Withdrawn |
NCT01340274 -
Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling
|
Phase 2 | |
Recruiting |
NCT02491996 -
The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers
|
N/A | |
Recruiting |
NCT01154712 -
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
|
Phase 1 | |
Completed |
NCT00927563 -
Tolcapone Treatment of Pathological Gambling
|
Phase 2 | |
Completed |
NCT01843699 -
Topiramate Trial for Pathological Gamblers
|
Phase 2 |